AI assistant
Sending…
RESMED INC — Director's Dealing 2021
Oct 14, 2021
30071_dirs_2021-10-14_f79819ab-3e8a-4fbb-8430-834e767cafab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-08-25
Reporting Person: Ghoshal Kaushik (President, SaaS Business)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 7370 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| ResMed Common Stock Options | $95.80 | 2025-04-02 | ResMed Common Stock (2086) | Direct | |
| ResMed Common Stock Options | $146.34 | 2026-11-21 | ResMed Common Stock (683) | Direct | |
| ResMed Common Stock Options | $211.76 | 2027-11-19 | ResMed Common Stock (472) | Direct | |
| ResMed Common Stock Options | $95.80 | 2025-04-02 | ResMed Common Stock (6877) | Direct | |
| ResMed Common Stock Options | $101.64 | 2025-11-14 | ResMed Common Stock (10297) | Direct | |
| ResMed Common Stock Options | $146.34 | 2026-11-21 | ResMed Common Stock (7095) | Direct | |
| ResMed Common Stock Options | $211.76 | 2027-11-19 | ResMed Common Stock (10608) | Direct |
Footnotes
F1: Corrects the number of outstanding options as of September 1, 2021.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29